<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04744935</url>
  </required_header>
  <id_info>
    <org_study_id>2020-5664</org_study_id>
    <nct_id>NCT04744935</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma</brief_title>
  <official_title>Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optical coherence tomography guided laser treatment of basal cell carcinoma&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this pilot study is to examine the treatment basal cell carcinoma (BCC) with&#xD;
      laser technology under the guidance of optical coherence tomography imaging (OCT). The laser&#xD;
      modality that we plan to use is the long-pulse Nd:YAG 1064nm laser, which is a non-ablative&#xD;
      laser already shown to effectively treat BCC. Laser treatment of BCC has limited precedent in&#xD;
      the literature, but the addition of OCT has the opportunity to enhance outcomes by better&#xD;
      targeting the treatment and permitting more precise monitoring of clearance. We propose to&#xD;
      use OCT imaging to guide the laser treatment to achieve optimal efficacy with minimized&#xD;
      side-effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete clearance of BCC lesion</measure>
    <time_frame>1 year</time_frame>
    <description>Those whose lesion is not in a cosmetically sensitive area will undergo a skin biopsy for histological confirmation of OCT results.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cosmetic outcome</measure>
    <time_frame>1 year</time_frame>
    <description>We assess cosmetic outcome and any adverse effects of the laser treatment as a result of the laser treatment, rated on a 0-4 Likert scaleworst cosmetic outcome and 4 resembling normal skin, upon follow-up of treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <condition>Superficial Basal Cell Carcinoma</condition>
  <condition>Nodular Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1064 Long-pulse Nd:YAG laser Fluence: 120 J/cm2 Number of passes: Single Spot size: 2 cm Pulse width: 8-10 msec</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Slow</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1064 Long-pulse Nd:YAG laser Fluence: 20-30 J/cm2 Number of passes: Multiple Spot size: 2 cm Pulse width: 8-10 msec</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1064 nm long-pulse Nd:YAG laser</intervention_name>
    <description>BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.</description>
    <arm_group_label>Slow</arm_group_label>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to understand and carry out subject instructions or be represented by a&#xD;
             legally authorized guardian or representative&#xD;
&#xD;
          -  Ages 18 and older&#xD;
&#xD;
          -  Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Any of the following will exclude participation in the study:&#xD;
&#xD;
          -  Inability to understand and/or carry out instructions&#xD;
&#xD;
          -  Patients with a BCC lesion that requires excision. This would include relatively large&#xD;
             lesions (&gt;2.5 cm diameter), lesions that penetrate deep into the skin beyond the depth&#xD;
             of the OCT image capture, high risk lesions as defined by the American Academy of&#xD;
             Dermatology as recurrent and sclerosing subtype BCC, or metastases.&#xD;
&#xD;
          -  Patients with periocular BCCs which might expose the patient to risk of damage to eyes&#xD;
             from the laser.&#xD;
&#xD;
          -  BCCs on legs due to their tendency towards poor wound healing.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patients unable to follow-up for the full 12 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erica G Baugh</last_name>
    <phone>6027430096</phone>
    <email>ebaugh@hs.uci.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCI Health Gottschalk Medical Plaza</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92617</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erica G Baugh</last_name>
    </contact>
    <investigator>
      <last_name>Christopher B Zachary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 4, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Basal cell carcinoma</keyword>
  <keyword>Superficial basal cell carcinoma</keyword>
  <keyword>Nodular basal cell carcinoma</keyword>
  <keyword>Optical coherence tomography</keyword>
  <keyword>OCT</keyword>
  <keyword>Laser</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

